AAAAAA

   
Results: 1-15 |
Results: 15
STIMULUS-DEPENDENT TRANSDUCTION MECHANISMS FOR NITRIC-OXIDE RELEASE IN HUMAN POLYMORPHONUCLEAR NEUTROPHIL LEUKOCYTES
Authors: LARFARS G GYLLENHAMMAR H
Citation: G. Larfars et H. Gyllenhammar, STIMULUS-DEPENDENT TRANSDUCTION MECHANISMS FOR NITRIC-OXIDE RELEASE IN HUMAN POLYMORPHONUCLEAR NEUTROPHIL LEUKOCYTES, The Journal of laboratory and clinical medicine, 132(1), 1998, pp. 54-60
AN EXPLORATORY TRIAL OF 2 DOSAGES OF A NOVEL SYNTHETIC THROMBIN INHIBITOR (NAPSAGATRAN, RO 46-6240) COMPARED WITH UNFRACTIONATED HEPARIN FOR TREATMENT OF PROXIMAL DEEP-VEIN THROMBOSIS - RESULTS OF THE EUROPEANMULTICENTER ADVENT TRIAL
Authors: BOUNAMEAUX H EHRINGER H HULTING J RASCHE H RAPOLD HJ ZULTAK M RAMES A BASLE CH TENCATE JW SCHNEIDER PA GENEVA CH SCHMITT HE SLOSMAN DO PERRIER A SPANNAGL H GSCHWANDTNER ME BANYAI M KOPPENSTEINER R MINAR E STUMPFLEN A HAUMER M VERHAEGHE R VERMYLEN J WAUTRECHT JC TAGHIZADEH K BRUHN HD LINS M ZURBORN KH SCHWARZENBERG H SCHAUER J SCHEEL H RUHLMANN C VOIGT H WAGNER T SIEMENS HJ SCHWIEDER G HEENE D DEMPFLE CE HARENBERG J PFITZNER S BROCKHAUS W SCHUSTER O WEISSHAAR K SEBIGER R HOFMANN B ANDERS O KRAMMER B PLATH F LESTIN H BAUMANN N EHRERTREICH U MULLERESCH G RUPRECHT B WEDEEN G LARFARS G WALLVIK J BJUHR O DIDIER D DESMARAIS S WUTSCHERT R DEMOERLOOSE P CHRISTEN Y BERNARD C KUPKA S KIRISITS A JANSSEN M VERWEIJ G KRAAJ CJ SITTNER WD HANKA U MAIER A JOHANSSON AS JOHANSSON E OLESEN M BREIER E WITTKE B GOGGIN T STEPHENSON C TURKISH M WILLIAMS L DUTREIX C GAUTSCH A NONN D WARD R LOWE P LAD K GREEN D GRAVEL A
Citation: H. Bounameaux et al., AN EXPLORATORY TRIAL OF 2 DOSAGES OF A NOVEL SYNTHETIC THROMBIN INHIBITOR (NAPSAGATRAN, RO 46-6240) COMPARED WITH UNFRACTIONATED HEPARIN FOR TREATMENT OF PROXIMAL DEEP-VEIN THROMBOSIS - RESULTS OF THE EUROPEANMULTICENTER ADVENT TRIAL, Thrombosis and haemostasis, 78(3), 1997, pp. 997-1002
THE DURATION OF ORAL ANTICOAGULANT-THERAPY AFTER A 2ND EPISODE OF VENOUS THROMBOEMBOLISM
Authors: SCHULMAN S GRANQVIST S HOLMSTROM M CARLSSON A LINDMARKER P NICOL P EKLUND SG NORDLANDER S LARFARS G LEIJD B LINDER O LOOGNA E GUSTAFSSON C GRONDAHL A RHEDIN AS TORNEBOHM E LOCKNER D JOHNSSON H KOBOSKO J MALMROS B ARCINI N SAAW J STIG R VIERING S LJUNGBERG B WILHELMSSON S OHLSSON A WALTER H MALMQVIST K ALKHALILI F PETRESCU A BROHULT J HULTING J SVENSSON E DAHLIN L BOBERG J MARJANOVICS B JONSSON KA MALM C HJORTH M LINDGREN A FAGRELL B KALLNER M WADMAN B SNYDER M
Citation: S. Schulman et al., THE DURATION OF ORAL ANTICOAGULANT-THERAPY AFTER A 2ND EPISODE OF VENOUS THROMBOEMBOLISM, The New England journal of medicine, 336(6), 1997, pp. 393-398
ELECTROCHEMICAL DETECTION OF NITRIC-OXIDE IN HUMAN POLYMORPHONUCLEAR GRANULOCYTES, IN-VIVO
Authors: LARFARS G GYLLENHAMMAR H
Citation: G. Larfars et H. Gyllenhammar, ELECTROCHEMICAL DETECTION OF NITRIC-OXIDE IN HUMAN POLYMORPHONUCLEAR GRANULOCYTES, IN-VIVO, Blood, 90(10), 1997, pp. 2896-2896
ANTIRHEUMATIC GOLD SALTS INHIBIT PRODUCTION OF NITRIC-OXIDE IN MURINEMACROPHAGES ACTIVATED WITH LIPOSACCHARIDE
Authors: GYLLENHAMMAR H LARFARS G BRATT J PALMBLAD J
Citation: H. Gyllenhammar et al., ANTIRHEUMATIC GOLD SALTS INHIBIT PRODUCTION OF NITRIC-OXIDE IN MURINEMACROPHAGES ACTIVATED WITH LIPOSACCHARIDE, Journal of investigative medicine, 44(3), 1996, pp. 298-298
THE SIGNIFICANCE OF HYPOFIBRINOLYSIS FOR THE RISK OF RECURRENCE OF VENOUS THROMBOEMBOLISM
Authors: SCHULMAN S WIMAN B CARLSSON A GUSTAFSSON C GRONDAHL A RHEDIN AS TORNEBOHM E JOHANSSON M LOCKNER D LINDMARKER P JOHNSSON H NICOL P KOBOSKO J MALMROS B ARCINI N SAAW J LOOGNA E STIG R VIERING S LJUNGBERG B WILHELMSSON S OHLSSON A WALTER H MALMQVIST K ALKHALILI F LEIJD B PETRESCU A BROHULT J LARFARS G HULTING J EKLUND SG SVENSSON E DAHLIN L BOBERG J NORDLANDER S MARJANOVICS B LINDER O JONSSON KA MALM C HJORTH M FAGRELL B KALLNER M GRANQVIST S EGBERG N SCHULMAN S WADMAN B SNYDER M
Citation: S. Schulman et al., THE SIGNIFICANCE OF HYPOFIBRINOLYSIS FOR THE RISK OF RECURRENCE OF VENOUS THROMBOEMBOLISM, Thrombosis and haemostasis, 75(4), 1996, pp. 607-611
LETTER OF APOLOGY
Authors: LARFARS G GYLLENHAMMAR H
Citation: G. Larfars et H. Gyllenhammar, LETTER OF APOLOGY, Journal of immunological methods, 199(2), 1996, pp. 211-211
FLUDARABINE, AS WELL AS 2-CHLORODEOXYADENOSINE, CAN INDUCE EOSINOPHILIA DURING TREATMENT OF LYMPHOID MALIGNANCIES
Authors: LARFARS G UDENBLOHME AM SAMUELSSON J
Citation: G. Larfars et al., FLUDARABINE, AS WELL AS 2-CHLORODEOXYADENOSINE, CAN INDUCE EOSINOPHILIA DURING TREATMENT OF LYMPHOID MALIGNANCIES, British Journal of Haematology, 94(4), 1996, pp. 709-712
HYPEREOSINOPHILA INDUCED BY NUCLEOSIDE ANALOGS DURING TREATMENT OF LYMPHOID MALIGNANCIES
Authors: SAMUELSSON J LARFARS G UDENBLOHME AM
Citation: J. Samuelsson et al., HYPEREOSINOPHILA INDUCED BY NUCLEOSIDE ANALOGS DURING TREATMENT OF LYMPHOID MALIGNANCIES, Blood, 88(10), 1996, pp. 2278-2278
A COMPARISON OF 6 WEEKS WITH 6 MONTHS OF ORAL ANTICOAGULANT-THERAPY AFTER A FIRST EPISODE OF VENOUS THROMBOEMBOLISM
Authors: SCHULMAN S RHEDIN AS LINDMARKER P CARLSSON A LARFARS G NICOL P LOOGNA E SVENSSON E LJUNGBERG B WALTER H VIERING S NORDLANDER S LEIJD B JONSSON KA HJORTH M LINDER O BOBERG J GUSTAFSSON C GRONDAHL A TORNEBOHM E JOHANSSON M LOCKNER D JOHNSSON H KOBOSKO J MALMROS B ARCINI N SAAW J STIG R WILHELMSSON S OHLSSON A MALMQVIST K ALKHALILI F PETRESCU A BROHULT J HULTING J EKLUND SG DAHLIN L MARJANOVICS B MALM C LINDGREN A FAGRELL B KALLNER M GRANQVIST S WIMAN B EGBERG N WADMAN B SNYDER M
Citation: S. Schulman et al., A COMPARISON OF 6 WEEKS WITH 6 MONTHS OF ORAL ANTICOAGULANT-THERAPY AFTER A FIRST EPISODE OF VENOUS THROMBOEMBOLISM, The New England journal of medicine, 332(25), 1995, pp. 1661-1665
MEASUREMENT OF METHEMOGLOBIN FORMATION FROM OXYHEMOGLOBIN - A REAL-TIME, CONTINUOUS ASSAY OF NITRIC-OXIDE RELEASE BY HUMAN POLYMORPHONUCLEAR LEUKOCYTES
Authors: LARFARS G GYLLENHAMMAR H
Citation: G. Larfars et H. Gyllenhammar, MEASUREMENT OF METHEMOGLOBIN FORMATION FROM OXYHEMOGLOBIN - A REAL-TIME, CONTINUOUS ASSAY OF NITRIC-OXIDE RELEASE BY HUMAN POLYMORPHONUCLEAR LEUKOCYTES, Journal of immunological methods, 184(1), 1995, pp. 53-62
QUALITY OF ORAL ANTICOAGULANT CONTROL AND TREATMENT IN SWEDEN
Authors: SCHULMAN S CARLSSON A GUSTAFSSON C GRONDAHL A RHEDIN AS TORNEBOHM E JOHANSSON M LOCKNER D LINDMARKER P JOHNSSON H NICOL P KOBOSKO J MALMROS B ARCINI N SAAW J LOOGNA E STIG R VIERING S LJUNGBERG B WILHELMSSON S OHLSSON A WALTER H MALMQVIST K ALKHALILI F LEIJD B PETRESCU A BROHULT J LARFARS G HULTING J EKLUND SG SVENSSON E DAHLIN L BOBERG J NORDLANDER S MARJANOVICS B LINDER O JONSSON KA MALM C HJORT M FAGRELL B KALLNER M GRANQVIST S WIMAN B EGBERG N
Citation: S. Schulman et al., QUALITY OF ORAL ANTICOAGULANT CONTROL AND TREATMENT IN SWEDEN, Journal of internal medicine, 236(2), 1994, pp. 143-152
STUDIES OF FMLP, LTB4, LTD4, AND PMA INDUCED NITRIC-OXIDE PRODUCTION IN HUMAN NEUTROPHIL GRANULOCYTES
Authors: LARFARS G GYLLENHAMMAR H
Citation: G. Larfars et H. Gyllenhammar, STUDIES OF FMLP, LTB4, LTD4, AND PMA INDUCED NITRIC-OXIDE PRODUCTION IN HUMAN NEUTROPHIL GRANULOCYTES, Blood, 84(10), 1994, pp. 10000035-10000035
ORAL 2-CHLORODEOXYADENOSINE (CDA) AS PRIMARY-TREATMENT FOR SYMPTOMATIC CHRONIC LYMPHOCYTIC-LEUKEMIA (CLL)
Authors: JULIUSSON G JOHNSON SAN CHRISTIANSEN I KIMBY E BJORKHOLM M LARFARS G LILIEMARK J
Citation: G. Juliusson et al., ORAL 2-CHLORODEOXYADENOSINE (CDA) AS PRIMARY-TREATMENT FOR SYMPTOMATIC CHRONIC LYMPHOCYTIC-LEUKEMIA (CLL), Blood, 82(10), 1993, pp. 10000141-10000141
NITRIC-OXIDE PRODUCTION IN HUMAN POLYMORPHONUCLEAR NEUTROPHIL GRANULOCYTES
Authors: LARFARS G GYLLENHAMMAR H PALMBLAD J
Citation: G. Larfars et al., NITRIC-OXIDE PRODUCTION IN HUMAN POLYMORPHONUCLEAR NEUTROPHIL GRANULOCYTES, Blood, 82(10), 1993, pp. 10000511-10000511
Risultati: 1-15 |